180 related articles for article (PubMed ID: 31614566)
1. Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A-F Employing Taguchi Design-of-Experiments.
von Berg L; Stern D; Weisemann J; Rummel A; Dorner MB; Dorner BG
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614566
[TBL] [Abstract][Full Text] [Related]
2. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
3. Development of a fusion protein SNVP as substrate for assaying multi-serotype botulinum neurotoxins.
Luo S; Li T; Wang Q; Tian R; Liu H; Fang H; Chen F; Wang H
Anal Biochem; 2014 Oct; 463():75-81. PubMed ID: 23851341
[TBL] [Abstract][Full Text] [Related]
4. Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B, and E.
Hines HB; Kim AD; Stafford RG; Badie SS; Brueggeman EE; Newman DJ; Schmidt JJ
Appl Environ Microbiol; 2008 Feb; 74(3):653-9. PubMed ID: 18083881
[TBL] [Abstract][Full Text] [Related]
5. The in vitro detection of botulinum neurotoxin-cleaved endogenous VAMP is epitope-dependent.
Gray B; Cadd V; Elliott M; Beard M
Toxicol In Vitro; 2018 Apr; 48():255-261. PubMed ID: 29373835
[TBL] [Abstract][Full Text] [Related]
6. Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.
Hackett G; Moore K; Burgin D; Hornby F; Gray B; Elliott M; Mir I; Beard M
Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29751611
[TBL] [Abstract][Full Text] [Related]
7. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
[TBL] [Abstract][Full Text] [Related]
8. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
Chen S; Hall C; Barbieri JT
J Biol Chem; 2008 Jul; 283(30):21153-9. PubMed ID: 18511417
[TBL] [Abstract][Full Text] [Related]
9. A protein chip membrane-capture assay for botulinum neurotoxin activity.
Marconi S; Ferracci G; Berthomieu M; Kozaki S; Miquelis R; Boucraut J; Seagar M; Lévêque C
Toxicol Appl Pharmacol; 2008 Dec; 233(3):439-46. PubMed ID: 18845174
[TBL] [Abstract][Full Text] [Related]
10. Synaptic vesicle chips to assay botulinum neurotoxins.
Ferracci G; Miquelis R; Kozaki S; Seagar M; Lévêque C
Biochem J; 2005 Nov; 391(Pt 3):659-66. PubMed ID: 16011482
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
Pellett S; Tepp WH; Scherf JM; Johnson EA
PLoS One; 2015; 10(7):e0133737. PubMed ID: 26207366
[TBL] [Abstract][Full Text] [Related]
12. Protein Domain Analysis of C. botulinum Type A Neurotoxin and Its Relationship with Other Botulinum Serotypes.
Sharma SK; Basavanna U; Shukla HD
Toxins (Basel); 2010 Jan; 2(1):1-9. PubMed ID: 22069543
[TBL] [Abstract][Full Text] [Related]
13. High level expression of the light chain of botulinum neurotoxin serotype C1 and an efficient HPLC assay to monitor its proteolytic activity.
Rawat R; Ashraf Ahmed S; Swaminathan S
Protein Expr Purif; 2008 Aug; 60(2):165-9. PubMed ID: 18482846
[TBL] [Abstract][Full Text] [Related]
14. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.
Wang D; Krilich J; Pellett S; Baudys J; Tepp WH; Barr JR; Johnson EA; Kalb SR
Biochim Biophys Acta; 2013 Dec; 1834(12):2722-8. PubMed ID: 24096023
[TBL] [Abstract][Full Text] [Related]
16. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.
Sikorra S; Henke T; Galli T; Binz T
J Biol Chem; 2008 Jul; 283(30):21145-52. PubMed ID: 18511418
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium.
Zhang S; Lebreton F; Mansfield MJ; Miyashita SI; Zhang J; Schwartzman JA; Tao L; Masuyer G; Martínez-Carranza M; Stenmark P; Gilmore MS; Doxey AC; Dong M
Cell Host Microbe; 2018 Feb; 23(2):169-176.e6. PubMed ID: 29396040
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
Raciborska DA; Trimble WS; Charlton MP
Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
[TBL] [Abstract][Full Text] [Related]
19. Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells.
Purkiss JR; Friis LM; Doward S; Quinn CP
Neurotoxicology; 2001 Aug; 22(4):447-53. PubMed ID: 11577803
[TBL] [Abstract][Full Text] [Related]
20. Uptake of botulinum neurotoxin into cultured neurons.
Keller JE; Cai F; Neale EA
Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
